Therapeutic Asset Ratings

160 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Valproic Acid Bipolar I Disorder	Bristol-Myers Squibb	P4	BBB (74)
LAMOTRIGINE Bipolar 1 Disorder	Bristol-Myers Squibb	P4	BBB (73)
Paroxetine Bipolar I Disorder	Bristol-Myers Squibb	P4	BBB (72)
Docetaxel Adenocarcinoma of the Pancreas	Bristol-Myers Squibb	P2	BBB (72)
Nivolumab Metastatic Melanoma	Bristol-Myers Squibb	P4	BB (70)
Ozanimod Multiple Sclerosis, Relapsing-Remitting	Bristol-Myers Squibb	P4	BB (70)
Nivolumab Colorectal Neoplasm	Bristol-Myers Squibb	P3	BB (70)
Nivolumab Melanoma	Bristol-Myers Squibb	P4	BB (69)
Mosunetuzumab Non-Hodgkin Lymphoma	Bristol-Myers Squibb	P3	BB (68)
Relatlimab Neoplasms by Site	Bristol-Myers Squibb	P2	BB (68)
Relatlimab Metastatic Melanoma	Bristol-Myers Squibb	P4	BB (66)
Admilparant Pulmonary Fibrosis	Bristol-Myers Squibb	P3	BB (66)
Luspatercept Thalassemia Major	Bristol-Myers Squibb	P4	BB (65)
immunoglobulin G1-kappa, anti-[Fucosyl-GM1 (fucosylated monosialoganglioside 1)], Homo sapiens monoclonal antibody; H-gamma1 heavy chain Homo sapiens (1-452) [VH (Homo sapiens IGHV3-4802 (90.7%) -(IGHD) -IGHJ301 (92.3%) M123>T (117), CDR-IMGT [8.8.15] (26-33.51-58.97-111)) (1-122) -Homo sapiens IGHG103 (100%), G1m3, nG1m1 CH1 R120, CH3 E12, M14 (CH1 R120 (219) (123-220), hinge 1-15 (221-235), CH2 (236-345), CH3 E12 (361), M14 (363) (346-450), CHS (451-452)) (123-452)], (225-214')-disulfide with L-kappa light chain Homo sapiens (1'-214') [V-KAPPA (Homo sapiens IGKV1D-1601 (100%) -IGKJ401 (100%), CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC01 (100%), Km3 A45.1 (153'), V101 (191') (108'-214')]; dimer (231-231'':234-234'')-bisdisulfide, produced in a Chinese hamster ovary (CHO) cell line lacking the enzyme alpha-(1,6)-fucosyltransferase (FUT8), glycoform alfa Small Cell Lung Cancer	Bristol-Myers Squibb	P3	BB (65)
Famotidine Anemia, Sickle Cell	Bristol-Myers Squibb	P2/3	BB (65)
Carboplatin Neoplasms	Bristol-Myers Squibb	P3	BB (64)
Carboplatin Solid Tumors	Bristol-Myers Squibb	P3	BB (64)
Luspatercept Beta-Thalassemia	Bristol-Myers Squibb	P3	BB (64)
Pumitamig Microsatellite Stable Colorectal Cancer	Bristol-Myers Squibb	P2/3	BB (64)
Relatlimab Melanoma	Bristol-Myers Squibb	P4	B (63)
BMS-986374 Relapsing Multiple Sclerosis	Bristol-Myers Squibb	P4	B (62)
Nivolumab Small Cell Lung Cancer	Bristol-Myers Squibb	P2	B (62)
Relatlimab Advanced Cancer	Bristol-Myers Squibb	P2	B (62)
Karx-Ec Agitation	Bristol-Myers Squibb	P3	B (60)
Karxt Agitation	Bristol-Myers Squibb	P3	B (60)

Showing 1 to 25 of 160 assets

PreviousPage 1 of 7Next